New Technical Jewelry Symposium To Premiere At Vicenzaoro Jewelry Fair
For the first time in its 70-year history, the Vicenzaoro jewelry trade fair will host an adjacent gathering dedicated to metallurgy and jewelry manufacturing processes. Called the Vicenza Symposium, it will be held September 2 -4 Vicenza, Italy, prior to Vicenzaoro on September 5 -7.
Both events are B2B focused, open only to the jewelry trade.
The Vicenza Symposium is modeled after the Santa Fe Symposium with the objective of advancing jewelry making technology, the science of adornment if you will. The three-day event is modeled after the Santa Fe Symposium, founded in 1987 by Eddie Bell, the retired CEO of Rio Grande, an Albuquerque, N.M., company the manufactures, markets and sells jewelry-making supplies. He held his last symposium in 2022 following his retirement. By this time, it was the world's most important event on the technology and science of metallurgy and jewelry making, attracting professionals from around the world. This new event is an attempt to maintain the community that Bell established. In fact, Bell was named honorary president and will deliver opening remarks.
There will be 21 white papers delivered during the three-day event on artificial intelligence, 3D printing and other highly technical topics. Presentations will range from 'Gold in the Age of SLM-CNC Interface,' and 'Cracks, pores and other defects in jewellery – their causes and their prevention' to 'Potential of Pt-and-pd-based Bulk Metallic Glasses for Jewellery applications.'
It is fitting that it's established the Italian gold jewelry center of Vicenza, known as much for the technology of goldsmithing and jewelry making as well as it is for manufacturing jewels in the tradition of Italian design and style.
FEATURED | Frase ByForbes™
Unscramble The Anagram To Reveal The Phrase
Pinpoint By Linkedin
Guess The Category
Queens By Linkedin
Crown Each Region
Crossclimb By Linkedin
Unlock A Trivia Ladder
Familiar Names at Vicenzaoro
When Vicenzaoro opens September 5 at the IEG's Expo Centre, it will once again be a showplace for internationally known Italian jewelry brands such as Roberto Coin, Annamaria Cammilli, Damiani, Nanis, Fope and Crivelli. The revival of the historic Marina B jewelry brand will also be a focus of the show.
The fair attracts important jewelers from Europe and other parts of the world as well including Schreiner Fine Jewellery from Germany, Fabergé from the UK, Etho Maria from Greece, Carrera Y Carrera from Spain, and Statement Paris and D1928 from France.
Outside Europe, the Australian pearl jewelry company, Autore, will present its new high jewelry and fine jewelry designs.
One of the returning features of Vicenzaoro is 'The Design Room,' for independent high-end designers. This is one of the very few international venues where these designers can have a proper place to show their creations as most international jewelry shows focus on large manufacturers. These designers reinterpret jewelry with unique and exclusive creations. Among the best-known names are Alessio Boschi, whose creations combine culture, history and architecture; Mike Joseph, who focuses of geometric design studded with diamonds; Antonini Milano for lovers of pure yet structured lines; and Karen Suen who combines modern glam with classic jewelry techniques.
In addition, there's 'The 8' project, a creation of Boschi, fellow jewelry designers Alessia Crivelli and Luca Daverio, and the goldsmith foundation, Mani Intelligenti. The project promotes new Italian and international jewelry talents.
There's also a specific space for the watchmaking brands and accessories, a growing sector of the trade fair with more than 40 exhibitors.
All totaled the September Vicenzaoro jewelry trade fair is expected to attract more than 450 buyers from 60 countries who will view the products and services of approximately 1,200 exhibitors from 35 countries.
In its 70th year, Vicenzaoro claims to be the world's longest-running jewelry trade event. Vicenzaoro is held twice each year. Following the September show the next fair will be held January 16 – 20, 2026. Vicenzaoro and the Vicenza Symposium is owned and operated by the Italian Exhibition Group (IEG), an international trade show company based in Rimini, Italy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
The FTSE 100's at record highs! But is it about to plummet?
The FTSE 100 has enjoyed a stellar year, so far. Up 10.7% since 1 January, it's outperformed multiple other major blue-chip share indices including the S&P 500 (up 7.3%), Nasdaq (up 8.5%) and the Nikkei (up 3.2%). In that time, it's touched record highs, approaching 9,200 points over the past week. And it looks poised to hit new all-time peaks given strong demand for undervalued UK shares. Or does it? Data from IG suggests that investor sentiment may actually be turning against the Footsie — it shows shorting activity involving the index rose 34% last month. Shorting involves traders borrowing an asset and selling it, on the hope of buying it back more cheaply later on. But what are the chances of a full-blown correction? And what steps should I, as holder of FTSE 100 stocks, protect myself from such an event? Red lights flashing? On the one hand, the recent shorting boom will partly reflect investors looking to capitalise on a fall as individuals book profits. Short-term pullbacks are common during strong bull runs for this reason; they don't necessarily mark a broader reversal in market confidence. However, the red lights are flashing as trade tariffs bite and the global economy cools. Chief investment officer Mike Wilson of Morgan Stanley puts the chances of an S&P 500 correction at 10% by the end of the year, he told Bloomberg. Other brokerages and banks put the chances of a retracement still higher. On the one hand, this may reflect the sky-high valuations many US shares still command. Yet with a large contingent of cyclical shares (like banks, miners, airlines and energy producers), the FTSE may also decline if economic conditions worsen and sentiment sours. Correction? So what? Yet I'm not panicking about what may be around the corner. This is because stock markets have a habit of rebounding sharply from corrections. The Footsie is a prime example, recovering from multiple catastrophes like pandemics, banking sector meltdowns, wars and sovereign debt crises down the years, and culminating in July's record highs. This shows how patient investors are rewarded for not selling up and running for the hills. In fact, those that buy in when shares fall can enjoy supersized returns when the market recovers. It's a strategy that made me money when global stock markets fell sharply earlier this year. So I'm holding cash to jump in again and go bargain-shopping if they drop again. Ashtead Group's (LSE:AHT) one FTSE 100 share I'll be looking to buy if prices fall in the near future. I think it could be a strong contender to fall given the raft of patchy data coming from the US. The rental equipment supplier makes 92% of revenues from North America. It may drop heavily, in fact. But I'd expect Ashtead shares to recover strongly over the long term. The landscape's rich with opportunity as major new infrastructure projects come on stream. And the company has significant scope and financial strength to capitalise on this through further acquisitions. Over two-thirds of the US market's controlled by smaller companies (ie those outside the four largest operators). This leaves Ashtead's Sunbelt brand (which has an 11% market share) room for more significant expansion. The post The FTSE 100's at record highs! But is it about to plummet? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Royston Wild has positions in Ashtead Group Plc. The Motley Fool UK has recommended Ashtead Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Rise of PocDoc: The DIY heart checker which delivers results in 10 minutes
As a 15-year-old, Steve Roest decided to spend eight weeks in Germany to live with a family that spoke no English. While there, he also learned to fly a plane 'under dubious circumstances' and later returned to the UK fluent in German. Ten years later he was made commercial director of global ticketing platform Viagogo and put his language skills to good use to scale its German operations with football's Bundesliga. 'I really like hard problems to solve,' says Roest. 'I believe in enforced humility, where you put yourself into a new situation that's complex and you're forced to learn in a really humble way. That's been my experience in my whole leadership career where I've been out of my depth but tried to learn quickly.' Roest has taken this approach into his latest venture with PocDoc, a UK-leading digital health diagnostics start-up, where he is co-founder and CEO and the leadership theme continues. 'There are few things harder in start-up life than building complex medical devices from scratch,' he explains. Read More: 'I pitched my car finance idea to my mother-in-law and she got it straight away' 'We were told on many occasions that it would be very difficult or borderline impossible. But we didn't consider ourselves to be the smartest people in the room [as we sought advice].' The British-born digital diagnostics company and its 'healthy heart check', which costs £19.99, now aims to revolutionise the way people test for cardiovascular diseases. The at-home, finger-prick test delivers a full cholesterol profile, BMI score, calculates heart age, and provides a ten-year risk assessment for heart attacks or strokes. The results are processed in 10 minutes and appear instantly, with any problems shared directly with a GP via the NHS app. Based in Cambridge, PocDoc started from a laboratory in early 2020 – the diagnostics provider had also tested for polio in Pakistan – while its heart checker took under three years to build, with 20 scientists and software engineers at the helm. With 40 staff today, PocDoc can now produce 3m units annually from its UK manufacturing facility. The vision was to focus on screening large volumes of people faster and more affordably than trying to get potential patients into a GP surgery which, says Roest, has limitations. He had entered into the business insistent on getting to the nub of the issue for the customer: the healthcare system. 'It doesn't need a new test per se, it needs a new way to affordably stop people having strokes, heart attacks, developing Type 2 diabetes and developing chronic kidney disease,' says Roest. Read More: A naval officer's submarine saga inspired me to become a leader There was also a personal pull. When he was 14, Roest's father had a stroke due to an undiagnosed cardiovascular disease which had a catastrophic effect on his family. 'It had a huge impact on me on the fragility of life,' he says. 'It created this drive to solve things today rather than wait for tomorrow.' His father, Jerry, had previously ran Compuserve as VP Europe and, following his stroke recovery, he then became song identifier Shazam's first CEO. Roest junior, who had studied German and linguistics at Oxford University, scaled to 80 markets worldwide over a decade at Viagogo. He left as the company crossed the $2bn ($1.5bn) ticket line. 'It gave me an incredible perspective when we started PocDoc,' he says. One of the three PocDoc co-founders is also his wife, Kiran, a life sciences specialist. She had been working with a colleague highly-cited in the point-of-care testing space, Dr Vladimir Gubala, who was also writing a research paper around using smartphone tech with quantitative blood testing. With his venture tech entrepreneurship, Roest mentioned to the pair that either the research paper was published or a business case could be made. Five years on – with PocDoc having raised £10m investment – Roest cites stories of PocDoc's work in the North East and Yorkshire with communities who aren't able or willing to access GP care. 'We are finding a high percentage of people that are at serious risk of having heart attack or stroke and getting them into treatment,' he says. 'There was a 21% increase in prescribed medication as a result of the programmes we have been involved in.' The firm has also partnered with women's groups as a way of screening in community centres in a manner they not only feel comfortable with but who had also been previously unknown to the healthcare system. Meanwhile, in the Cambridge area, PocDoc had approached serial non-responders via the local NHS system. A single text message was sent out to multiple thousands for a health heart check at home with an 80% uptake within 48 hours. 'It's not that they didn't want to take care of their health, there previously wasn't an effective, usable product that they could conveniently interact with,' admits Roest, who also hosts the HealthTech hour, Europe's largest health tech podcast. In May, the British Heart Foundation warned that the UK's heart health has declined more quickly at the start of the 2020s than in any other decade for over 50 years. It is one of the reasons why PocDoc has teamed up with high street chain Superdrug to make more under-40s aware of their health risks. Roest says that over half of this age category PocDoc screened have a heart age that is five years older than their real age. 'This isn't just an older person's issue anymore,' adds Roest. PocDoc now views the area of its prevention as a $100bn market globally, with the British firm hoping to make a sizable revenue dent into that figure over the next three years. Read More: 'I moved schools every six months. Now I run a thriving business network' Roest anticipates exporting to 10 international markets by the end of the year and a US launch in late 2026. With a multi seven-year figure turnover, PocDoc is on course for half a million orders since launch. In effect, it is now the default product both in the healthcare system for running community workplace and home screenings, as well as being the No.1 diagnostic product on the UK high street, outside of COVID and pregnancy. 'I'm a good news bearer and don't believe in moaning,' adds Roest. 'The NHS gets moaned at by everybody but we have been the opposite of that and are bringing good news to the table.' View from the top: Steve Roest on.. The best advice My father told me: 'Don't let the bastards grind you down'. He started saying it during the dotcom crash and it became a motto. The only definite way you lose is if you quit. Giving back The Last Friday Club involves me giving up my time on the last Friday of every month for free, predominantly helping people in the health tech, start-up and clinical space. I am doing that because I wish someone had done it during my entrepreneurial career. Read more: The boss who has found 'nature's answer to plastic' 'I had one good idea and turned it into a £3m voiceover and talent success' The life lesson behind a 335-year-old funeral business? 'Never sleep on an argument'Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
2 top ETFs that could turn £500 a month into a £1m retirement fund!
Exchange-traded funds (ETFs) are a rapidly growing asset class the world over. They allow individuals to target market-beating returns while, at the same time, helping them to manage risk by spreading their capital across a basket of assets. Investors can choose from thousands of funds that match their investment goals and tolerance of risk. I myself own several in my Self-Invested Personal Pension (SIPP). And I'm looking for more that could deliver strong capital gains and a reliable dividend income I can reinvest for growth. Here are two on my radar today. If they continue to deliver the returns of the last five years, they'll turn a £500 monthly investment into an impressive £1.2m over the next 25 years. Digging for huge returns Mining is notoriously unpreditable and fraught with risk for companies. Exploration disappointments, project delays, and production outages can play havoc with profits forecasts and decimate share prices. ETFs that invest in a basket of minerals producers don't completely eliminate this threat. Operational problems at one major holding can substantially impact overall returns. But on balance, I think funds are far less risky than purchasing individual mining stocks. I'm looking for a low-risk way to capitalise on a likely rise in copper prices over the next decade. And so I'm thinking of adding the Global X Copper Miners ETF (LSE:COPX) to my SIPP. As the chart shows, the copper market faces substantial shortfalls in the coming years, which I believe could drive up prices: In total, the fund holds shares in 40 red metal producers including First Quantum Minerals, Lundin Mining, and UK-listed share Antofagasta. Owning a fund that owns copper stocks instead of a fund that tracks metal prices can be more lucrative in bull markets — because copper miners have fixed costs, their profits grow faster than metal prices, delivering superior capital gains for investors. This leverage effect means that, since August 2020, this Global X copper fund has delivered a healthy average annual return of 10%. Emerging market opportunity As well as boosting my copper market exposure, I'm looking to improve my exposure to emerging markets. For this reason, the Franklin FTSE India UCITS ETF (LSE:FLXI) is on my list of possible funds to buy. India is the world's fastest growing economy — the International Monetary Fund is tipping GDP growth of 6.5% in the next two years. And it has significant scope for breakneck long-term growth, driven by its booming population, robust private investment, and rapidly rising personal wealth levels. These phenomena have already driven an average annual return of 17.1% for the Franklin FTSE India fund over the last five years. I like this ETF because of its excellent diversification. In total, it holds shares in 263 companies, from HDFC Bank and Bharti Airtel to Tata Motors and Sun Pharmaceutical. This helps reduce risk and provide exposure to a wide range of growth and income opportunities. Future performance could be impacted by US trade tariffs and reciprocal action from India's government. But on balance, I think it's another top fund for me to consider. The post 2 top ETFs that could turn £500 a month into a £1m retirement fund! appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended HDFC Bank. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
